Navigating Heart Transplantation in a Highly Sensitized Patient with Takayasu Arteritis: The Role of Perioperative Desensitization
Open Access
- 28 October 2026
- journal article
- case report
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8383
Abstract
Introduction: Takayasu arteritis (TA) is a rare large-vessel vasculitis that in selected patients can lead to severe cardiovascular complications, including advanced heart failure (HF), requiring heart transplantation (HTx). Marked pre-transplant high levels of anti-HLA antibodies and notable sensitization substantially complicate donor selection and may prolong time spent on transplant waitlists. In highly sensitized recipients, HTx may therefore require individualized perioperative desensitization strategies to reduce the risk of antibody-mediated graft injury. Case Summary: We present the case of a 46-year-old woman with TA and advanced HF who underwent HTx after individualized perioperative desensitization in the setting of significant pre-transplant sensitization (PRA > 60%). Her postoperative course required intensive clinical and immunological monitoring and treatment. The early PT course was complicated by severe clinical deterioration, including a life-threatening episode of asystole that occurred in temporal association with peak anti-HLA class I and II antibody levels. Discussion: The case highlights the complexity of alloimmune management in a patient with TA and marked pre-transplant sensitization. Also, the temporal relationship between peak antibody levels and clinical instability suggests the need for close immune surveillance, tailored desensitization and individualized immunosuppressive treatment strategies in this high-risk group. Conclusions: This case describes the clinical course of a highly sensitized patient with TA who underwent HTx following an individualized perioperative desensitization strategy based on a modified Hannover protocol. Although transplantation was followed by substantial postoperative complications, the patient remained clinically stable during follow-up. The efficacy of the modified desensitization strategy cannot be established from a single case.Keywords
Funding Information
- Wroclaw Medical University
This publication has 32 references indexed in Scilit:
- Transfusion-induced HLA sensitization in wait-list patients and kidney transplant recipientsKidney International, 2024
- Unusual manifestations of Takayasu arteritis: A diagnostic challengeClinical Case Reports, 2024
- The International thoracic organ transplant registry of the international society for heart and lung transplantation: Thirty-ninth adult heart transplantation report—2022; focus on transplant for restrictive heart diseaseThe Journal of Heart and Lung Transplantation, 2022
- Electrical storm in a patient with Takayasu arteritis and inferior myocardial scarHeartRhythm Case Reports, 2021
- Takayasu Arteritis: a Systematic Review and Meta‐Analysis of Test Accuracy and Benefits and Harms of Common TreatmentsACR Open Rheumatology, 2021
- Advances in personalized medicine and noninvasive diagnostics in solid organ transplantationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2020
- Ischemic Cardiomyopathy Due to Localized Takayasu Arteritis Treated by Heart Transplantation Following Left Ventricular Assisted Device Implantation: A Case ReportTransplantation Proceedings, 2019
- Utility and Safety of Tocilizumab in Takayasu Arteritis with Severe Heart Failure and Muscle WastingESC Heart Failure, 2019
- Diagnostic Features, Treatment, and Outcomes of Takayasu Arteritis in a US Cohort of 126 PatientsMayo Clinic Proceedings, 2013
- Pathological studies on Takayasu arteritisHeart and Vessels, 1992